Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,616,000 | 1,739,000 | 1,452,000 | 1,237,000 | 1,514,000 |
| Receivables | 1,416,000 | 1,496,000 | 1,502,000 | 1,487,000 | 1,508,000 |
| Inventories | 812,000 | 781,000 | 725,000 | 814,000 | 837,000 |
| Income taxes - deferred | 931,000 | 873,000 | 679,000 | 637,000 | 607,000 |
| Other current assets | 0 | 0 | 1,119,000 | 196,000 | 0 |
| TOTAL | $5,168,000 | $5,241,000 | $5,941,000 | $4,687,000 | $4,936,000 |
| Non-Current Assets | |||||
| PPE Net | 1,738,000 | 1,736,000 | 1,715,000 | 1,764,000 | 1,779,000 |
| Investments And Advances | 122,000 | 321,000 | 317,000 | 435,000 | 535,000 |
| Intangibles | 0 | 0 | 23,067,000 | 24,272,000 | 23,816,000 |
| Other Non-Current Assets | 22,873,000 | 23,048,000 | 157,000 | 176,000 | 199,000 |
| TOTAL | $24,733,000 | $25,105,000 | $25,256,000 | $26,647,000 | $26,329,000 |
| Total Assets | $29,901,000 | $30,346,000 | $31,197,000 | $31,334,000 | $31,265,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 254,000 | 654,000 |
| Accounts payable and accrued liabilities | 222,000 | 222,000 | 139,000 | 2,620,000 | 1,888,000 |
| Accrued Expenses | 2,199,000 | 2,200,000 | 2,541,000 | N/A | N/A |
| Other current liabilities | 176,000 | 226,000 | 192,000 | 502,000 | 427,000 |
| TOTAL | $3,035,000 | $3,393,000 | $3,250,000 | $3,376,000 | $2,969,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 7,014,000 | 7,311,000 | 7,933,000 | 7,903,000 | 8,250,000 |
| Other Non-Current Liabilities | 1,965,000 | 2,021,000 | 2,633,000 | 2,114,000 | 1,561,000 |
| TOTAL | $11,231,000 | $11,562,000 | $12,850,000 | $12,441,000 | $12,494,000 |
| Total Liabilities | $14,266,000 | $14,955,000 | $16,100,000 | $15,817,000 | $15,463,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,500,640 | 1,496,258 | 1,492,321 | 1,490,786 | 1,489,553 |
| Common Shares | 15,000 | 15,000 | 15,000 | 15,000 | 15,000 |
| Retained earnings | -275,000 | -373,000 | -693,000 | -239,000 | 33,000 |
| Other shareholders' equity | 3,000 | -81,000 | -13,000 | 11,000 | 87,000 |
| TOTAL | $15,635,000 | $15,391,000 | $15,097,000 | $15,517,000 | $15,802,000 |
| Total Liabilities And Equity | $29,901,000 | $30,346,000 | $31,197,000 | $31,334,000 | $31,265,000 |